Healthcare provider profile · identity verified

Albert Harry Zucker, MD

Internal Medicine · MONROE, NY · NPI 1740256239

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	426	111
Amlodipine Besylate	Amlodipine Besylate	400	120
Rosuvastatin Calcium	Rosuvastatin Calcium	306	99
Losartan Potassium	Losartan Potassium	262	72
Metoprolol Succinate	Metoprolol Succinate	242	67
Metformin Hcl	Metformin Hcl	237	74
Levothyroxine Sodium	Levothyroxine Sodium	230	52
Lisinopril	Lisinopril	222	60
Hydrochlorothiazide	Hydrochlorothiazide	196	56
Pantoprazole Sodium	Pantoprazole Sodium	155	38
Simvastatin	Simvastatin	147	39
Omeprazole	Omeprazole	130	35
Zolpidem Tartrate	Zolpidem Tartrate	119	20
Tamsulosin Hcl	Tamsulosin Hcl	113	33
Metoprolol Tartrate	Metoprolol Tartrate	107	23
Sertraline Hcl	Sertraline Hcl	107	28
Allopurinol	Allopurinol	100	24
Eliquis	Apixaban	100	20
Famotidine	Famotidine	99	26
Glimepiride	Glimepiride	86	23
Potassium Chloride	Potassium Chloride	86	18
Azithromycin	Azithromycin	82	65
Escitalopram Oxalate	Escitalopram Oxalate	79	24
Alprazolam	Alprazolam	75	18
Jardiance	Empagliflozin	73	19
Furosemide	Furosemide	69	20
Montelukast Sodium	Montelukast Sodium	66	16
Clopidogrel	Clopidogrel Bisulfate	59	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	16
Sodium Chloride	0.9 % Sodium Chloride	59	17
Alendronate Sodium	Alendronate Sodium	58	14
Farxiga	Dapagliflozin Propanediol	58	suppressed
Januvia	Sitagliptin Phosphate	58	suppressed
Spironolactone	Spironolactone	58	16
Ezetimibe	Ezetimibe	56	15
Warfarin Sodium	Warfarin Sodium	56	suppressed
Trazodone Hcl	Trazodone Hcl	53	12
Torsemide	Torsemide	50	suppressed
Fluticasone Propionate	Fluticasone Propionate	49	15
Levetiracetam	Levetiracetam	47	suppressed
Gabapentin	Gabapentin	46	15
Mirtazapine	Mirtazapine	45	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	suppressed
Carvedilol	Carvedilol	44	suppressed
Valsartan	Valsartan	43	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	11
Albuterol Sulfate Hfa	Albuterol Sulfate	40	14
Prednisone	Prednisone	40	28
Xarelto	Rivaroxaban	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	13
Metformin Hcl Er	Metformin Hcl	36	11
Daptomycin	Daptomycin	35	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	31
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	15
Buspirone Hcl	Buspirone Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Donepezil Hcl	Donepezil Hcl	31	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Ramipril	Ramipril	29	suppressed
Mounjaro	Tirzepatide	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Heparin Sodium	Heparin Sodium,porcine	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Meropenem	Meropenem	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	23
Repaglinide	Repaglinide	25	suppressed
Finasteride	Finasteride	24	11
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Admelog Solostar	Insulin Lispro	22	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Nystatin	Nystatin	22	suppressed
Digoxin	Digoxin	21	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Baclofen	Baclofen	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	14
Lorazepam	Lorazepam	19	suppressed
Amiodarone Hcl	Amiodarone Hcl	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Ozempic	Semaglutide	17	suppressed
Alogliptin	Alogliptin Benzoate	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Chlorpromazine Hcl	Chlorpromazine Hcl	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Atenolol	Atenolol	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	14	suppressed
Cefuroxime	Cefuroxime Axetil	13	11
Celecoxib	Celecoxib	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Imipenem-Cilastatin Sodium	Imipenem/Cilastatin Sodium	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Metolazone	Metolazone	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Ropinirole Er	Ropinirole Hcl	12	suppressed
Scopolamine	Scopolamine	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ciclopirox	Ciclopirox Olamine	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Piperacillin-Tazobactam	Piperacillin Sodium/Tazobactam	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Wegovy	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error